Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy

Clinical trial NCT07600177 · RECRUITING

Trial details

NCT number: NCT07600177
Sponsor: Oregon Health and Science University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertrophic Cardiomyopathy (HCM)

Start date: 2026-05-05
Primary completion: 2026-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.